Table 6 Univariate and multivariable Cox proportional hazards model for OS in stage I-II melanoma patients
From: Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas
Characteristic | Univariate analysis | Multivariable analysis | ||
|---|---|---|---|---|
HR (95% CI) | p | HR (95% CI) | p | |
Age | ||||
≤ 55 vs.>55 | 0.413 (0.179–0.953) | 0.038* | 0.951 (0.407–2.221) | 0.908 |
Sex | ||||
Female vs. Male | 1.110 (0.499–2.471) | 0.797 | 0.326 (0.128–0.833) | 0.019* |
Location | ||||
Mucosa vs. Skin | 3.246 (1.031–10.225) | 0.044* | 1.619 (0.386–6.781) | 0.510 |
Acral vs. Skin | 1.242 (0.227–6.800) | 0.803 | 0.736 (0.102–5.324) | 0.736 |
Neuroendocrinea | 0.933 (0.412–2.112) | 0.868 | 0.775 (0.305–1.971) | 0.593 |
BRAF alternations | 0.330 (0.098–1.105) | 0.072 | 0.304 (0.065–1.417) | 0.129 |